102 related articles for article (PubMed ID: 7957633)
1. Phorbol esters alter functions of the expressed dopamine transporter.
Kitayama S; Dohi T; Uhl GR
Eur J Pharmacol; 1994 Jul; 268(2):115-9. PubMed ID: 7957633
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the functional activity of the human dopamine transporter by protein kinase C.
Zhang L; Coffey LL; Reith ME
Biochem Pharmacol; 1997 Mar; 53(5):677-88. PubMed ID: 9113087
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein.
Chang MY; Lee SH; Kim JH; Lee KH; Kim YS; Son H; Lee YS
J Neurochem; 2001 May; 77(3):754-61. PubMed ID: 11331404
[TBL] [Abstract][Full Text] [Related]
5. Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes.
Zhu SJ; Kavanaugh MP; Sonders MS; Amara SG; Zahniser NR
J Pharmacol Exp Ther; 1997 Sep; 282(3):1358-65. PubMed ID: 9316847
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway.
Zhang L; Reith ME
Eur J Pharmacol; 1996 Nov; 315(3):345-54. PubMed ID: 8982675
[TBL] [Abstract][Full Text] [Related]
7. Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax.
Huff RA; Vaughan RA; Kuhar MJ; Uhl GR
J Neurochem; 1997 Jan; 68(1):225-32. PubMed ID: 8978729
[TBL] [Abstract][Full Text] [Related]
8. Modeling of the interaction of Na+ and K+ with the binding of dopamine and [3H]WIN 35,428 to the human dopamine transporter.
Li LB; Reith ME
J Neurochem; 1999 Mar; 72(3):1095-109. PubMed ID: 10037481
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
[TBL] [Abstract][Full Text] [Related]
10. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
Xu C; Coffey LL; Reith ME
Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
[TBL] [Abstract][Full Text] [Related]
11. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
Wall SC; Innis RB; Rudnick G
Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.
Vaughan RA; Huff RA; Uhl GR; Kuhar MJ
J Biol Chem; 1997 Jun; 272(24):15541-6. PubMed ID: 9182590
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes.
Cowell RM; Kantor L; Hewlett GH; Frey KA; Gnegy ME
Eur J Pharmacol; 2000 Feb; 389(1):59-65. PubMed ID: 10686296
[TBL] [Abstract][Full Text] [Related]
14. RTI-76, an isothiocyanate derivative of a phenyltropane cocaine analog, as a tool for irreversibly inactivating dopamine transporter function in vitro.
Wang LC; Berfield JL; Kuhar MJ; Carroll FI; Reith ME
Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):238-47. PubMed ID: 10997726
[TBL] [Abstract][Full Text] [Related]
15. Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-ethylmaleimide-induced reduction of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)[3H]tropane ([3H]WIN 35,428) binding.
Reith ME; Xu C; Coffey LL
Biochem Pharmacol; 1996 Nov; 52(9):1435-46. PubMed ID: 8937455
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.
Kitayama S; Shimada S; Xu H; Markham L; Donovan DM; Uhl GR
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7782-5. PubMed ID: 1502198
[TBL] [Abstract][Full Text] [Related]
17. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
[TBL] [Abstract][Full Text] [Related]
18. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine-induced alterations in dopamine transporter function.
Bennett BA; Hollingsworth CK; Martin RS; Harp JJ
Brain Res; 1998 Jan; 782(1-2):219-27. PubMed ID: 9519266
[TBL] [Abstract][Full Text] [Related]
20. Isothiocyanate derivatives of cocaine: irreversible inhibition of ligand binding at the dopamine transporter.
Boja JW; Rahman MA; Philip A; Lewin AH; Carroll FI; Kuhar MJ
Mol Pharmacol; 1991 Mar; 39(3):339-45. PubMed ID: 1826041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
